ID   INP4B_RAT               Reviewed;         928 AA.
AC   Q9QWG5; O35825;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-OCT-2024, entry version 136.
DE   RecName: Full=Type II inositol 3,4-bisphosphate 4-phosphatase;
DE            EC=3.1.3.66 {ECO:0000269|PubMed:9295334};
DE   AltName: Full=Inositol polyphosphate 4-phosphatase type II;
GN   Name=Inpp4b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY, AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=9295334; DOI=10.1074/jbc.272.38.23859;
RA   Norris F.A., Atkins R.C., Majerus P.W.;
RT   "The cDNA cloning and characterization of inositol polyphosphate 4-
RT   phosphatase type II. Evidence for conserved alternative splicing in the 4-
RT   phosphatase family.";
RL   J. Biol. Chem. 272:23859-23864(1997).
CC   -!- FUNCTION: Catalyzes the hydrolysis of the 4-position phosphate of
CC       phosphatidylinositol 3,4-bisphosphate, inositol 1,3,4-trisphosphate and
CC       inositol 3,4-bisphosphate (PubMed:9295334). Plays a role in the late
CC       stages of macropinocytosis by dephosphorylating phosphatidylinositol
CC       3,4-bisphosphate in membrane ruffles (By similarity). The lipid
CC       phosphatase activity is critical for tumor suppressor function.
CC       Antagonizes the PI3K-AKT/PKB signaling pathway by dephosphorylating
CC       phosphoinositides and thereby modulating cell cycle progression and
CC       cell survival (By similarity). {ECO:0000250|UniProtKB:O15327,
CC       ECO:0000269|PubMed:9295334}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol-3-phosphate) + phosphate; Xref=Rhea:RHEA:17193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57658,
CC         ChEBI:CHEBI:58088; EC=3.1.3.66;
CC         Evidence={ECO:0000269|PubMed:9295334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 3,4-bisphosphate + H2O = 1D-myo-inositol 3-
CC         phosphate + phosphate; Xref=Rhea:RHEA:43388, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58401, ChEBI:CHEBI:83241;
CC         Evidence={ECO:0000269|PubMed:9295334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,3,4-trisphosphate + H2O = 1D-myo-inositol
CC         1,3-bisphosphate + phosphate; Xref=Rhea:RHEA:43392,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58414,
CC         ChEBI:CHEBI:83242; Evidence={ECO:0000269|PubMed:9295334};
CC   -!- ACTIVITY REGULATION: Strongly inhibited by inositol hexakisphosphate.
CC       {ECO:0000269|PubMed:9295334}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=39 uM for inositol 3,4-bisphosphate {ECO:0000269|PubMed:9295334};
CC         KM=34 uM for inositol 1,3,4-trisphosphate
CC         {ECO:0000269|PubMed:9295334};
CC         Vmax=26 umol/min/mg enzyme with inositol 3,4-bisphosphate as
CC         substrate {ECO:0000269|PubMed:9295334};
CC         Vmax=22 umol/min/mg enzyme with inositol 1,3,4-trisphosphate as
CC         substrate {ECO:0000269|PubMed:9295334};
CC       pH dependence:
CC         Optimum pH is 7-8. {ECO:0000269|PubMed:9295334};
CC   -!- PATHWAY: Signal transduction; phosphatidylinositol signaling pathway.
CC       {ECO:0000269|PubMed:9295334}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q9QWG5-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta;
CC         IsoId=Q9QWG5-2; Sequence=VSP_015249;
CC   -!- MISCELLANEOUS: [Isoform 2]: Inactive. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the inositol 3,4-bisphosphate 4-phosphatase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U96920; AAB72151.1; -; mRNA.
DR   EMBL; U96921; AAB72152.1; -; mRNA.
DR   RefSeq; NP_446369.1; NM_053917.1. [Q9QWG5-2]
DR   RefSeq; XP_008770684.1; XM_008772462.2. [Q9QWG5-2]
DR   RefSeq; XP_008770686.1; XM_008772464.2.
DR   RefSeq; XP_017456652.1; XM_017601163.1. [Q9QWG5-2]
DR   RefSeq; XP_017456653.1; XM_017601164.1.
DR   AlphaFoldDB; Q9QWG5; -.
DR   SMR; Q9QWG5; -.
DR   STRING; 10116.ENSRNOP00000025013; -.
DR   SwissLipids; SLP:000000896; -.
DR   iPTMnet; Q9QWG5; -.
DR   PhosphoSitePlus; Q9QWG5; -.
DR   PaxDb; 10116-ENSRNOP00000025013; -.
DR   Ensembl; ENSRNOT00000024981.7; ENSRNOP00000024981.4; ENSRNOG00000018382.7. [Q9QWG5-1]
DR   Ensembl; ENSRNOT00000025013.5; ENSRNOP00000025013.4; ENSRNOG00000018382.7. [Q9QWG5-2]
DR   Ensembl; ENSRNOT00055013428; ENSRNOP00055010753; ENSRNOG00055007963. [Q9QWG5-1]
DR   Ensembl; ENSRNOT00060020295; ENSRNOP00060015957; ENSRNOG00060011966. [Q9QWG5-1]
DR   Ensembl; ENSRNOT00065016487; ENSRNOP00065012532; ENSRNOG00065010215. [Q9QWG5-1]
DR   GeneID; 116699; -.
DR   KEGG; rno:116699; -.
DR   AGR; RGD:620470; -.
DR   CTD; 8821; -.
DR   RGD; 620470; Inpp4b.
DR   eggNOG; KOG4428; Eukaryota.
DR   GeneTree; ENSGT00940000157587; -.
DR   HOGENOM; CLU_007802_1_0_1; -.
DR   InParanoid; Q9QWG5; -.
DR   OMA; VITGRRX; -.
DR   OrthoDB; 5490552at2759; -.
DR   PhylomeDB; Q9QWG5; -.
DR   TreeFam; TF325637; -.
DR   BRENDA; 3.1.3.66; 5301.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-RNO-1855183; Synthesis of IP2, IP, and Ins in the cytosol.
DR   UniPathway; UPA00944; -.
DR   PRO; PR:Q9QWG5; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000018382; Expressed in heart and 17 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0017161; F:inositol-1,3,4-trisphosphate 4-phosphatase activity; IEA:RHEA.
DR   GO; GO:0052828; F:inositol-3,4-bisphosphate 4-phosphatase activity; IEA:RHEA.
DR   GO; GO:0008289; F:lipid binding; ISO:RGD.
DR   GO; GO:0034593; F:phosphatidylinositol bisphosphate phosphatase activity; ISO:RGD.
DR   GO; GO:0034594; F:phosphatidylinositol trisphosphate phosphatase activity; ISO:RGD.
DR   GO; GO:0016316; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; IDA:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0045671; P:negative regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:MGI.
DR   GO; GO:0046850; P:regulation of bone remodeling; ISO:RGD.
DR   GO; GO:0046822; P:regulation of nucleocytoplasmic transport; ISO:RGD.
DR   GO; GO:0051896; P:regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   CDD; cd04048; C2A_Copine; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR039034; INPP4.
DR   PANTHER; PTHR12187; AGAP000124-PA; 1.
DR   PANTHER; PTHR12187:SF3; INOSITOL POLYPHOSPHATE 4-PHOSPHATASE TYPE II; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   PROSITE; PS50004; C2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Hydrolase; Lipid metabolism; Reference proteome.
FT   CHAIN           1..928
FT                   /note="Type II inositol 3,4-bisphosphate 4-phosphatase"
FT                   /id="PRO_0000190239"
FT   DOMAIN          23..165
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          481..516
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          548..575
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        488..516
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         885..928
FT                   /note="REGCRIENVLKNIKCRRYAFNMLQLMAFPKCYRPPEGTYGKADT -> SRQT
FT                   QGALNESDDPETGCLSDNKPTSRHFYPVALLLVSSHLLVVWLILSLALLLAKYQ (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9295334"
FT                   /id="VSP_015249"
SQ   SEQUENCE   928 AA;  105245 MW;  973EB2EEA58E6430 CRC64;
     MEIKEEGTSE EGQHFLPAAQ ANDPEDIQFT SIQKSPNEPQ LEFILACKDL VAPVSDRKLN
     TVVQVSVIHP VEQTLTRYSS TEIVEGTKDP LFLTGVTFPS DYPIYEETRI KLTVYDVKDK
     PHDTIRTSVL PEHKDPPPEV ARSFLGCASF KVGELLKSKE QLLSLSLRTS DGGKVVGTIE
     VSLVKMGEIE DGDTDHITTD VQGQKCALVY DSTAPESLSG KENLPFMNAV LRNPVCKLYR
     FPTSDNKWMR IREQMSESIL SFHIPKELIS LHIKEDLCRN QELKELGDLS PHWDNLRNNV
     LSHCDQMVTM YQDILTELSK ETGSSFKSSS SKGEKTLEFV PINLHLQRMQ VHSPHLKDAL
     YDVITVGAPA AHFQGFKNGG LRKLLHRFET ERRNTGYQFI YYSPENTAKA KEVLSSINQL
     QPLVATHADL LLTSASQHSP DSLRSSLKLL SEKTELFVHA FKDQLVRSAL LALYTARPGG
     ILRKPPSPKV STEEKSSQHD SPQQLRRQDS IPHHSDYDEE EWDRVWANVG KSLNCIIAKV
     DKLIERDSRN DKSTGGDSSK DGDADPNLED SLTSHPREDW YEQLHPLILT LKECMAEVVN
     RAKQSLTFVL LQELAYSLPQ CLMLTLRRDI VFSQALAGLV CGFIIKLHTS LHDPGFLQQL
     HTVGLIVQYE GLLSTYSDEI GMLEDMAVGI SDLRKVAFKI TEATSNDVLP VLTGRREHYV
     VEVKLPATVF ESLPLQIKEG QLLHVYPVLF NVGINEQQTL AERFGDVSLQ ESINQENFEL
     VQEYYSIFME KMPPDYISHF QEQNDLKGLL DNLHQNIQAK KRKNVEIMWL AATICRKLNG
     IRFTCCKSAK DRTSMSVTLE QCSILRDEHQ LHKDFFIRAL DCMRREGCRI ENVLKNIKCR
     RYAFNMLQLM AFPKCYRPPE GTYGKADT
//
